Signet Investment Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Signet Investment Advisory Group's LLY Position: Q2 2026 in Review
Signet Investment Advisory Group reduced its Eli Lilly (LLY) stake by 0.64% in Q2 2026, selling an estimated $30.7K and leaving 4,634 shares worth $5.56M. The position accounts for 2.44% of the portfolio, ranked #16.
Signet Investment Advisory Group first reported a position in LLY in Q4 2018 and has held it in 28 quarters since. The position peaked at $6.73M in Q2 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Signet Investment Advisory Group held 4,634 shares of Eli Lilly worth $5.56M as of Q2 2026.
- Signet Investment Advisory Group sold 30 Eli Lilly shares in Q2 2026, an estimated $30.7K.
- Eli Lilly made up 2.44% of Signet Investment Advisory Group's portfolio in Q2 2026, its #16 holding.
- Signet Investment Advisory Group first reported a position in Eli Lilly in Q4 2018 and has held it in 28 quarters since.
- Signet Investment Advisory Group's Eli Lilly position peaked at $6.73M in Q2 2024.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Signet Investment Advisory Group's 13F filing for Q2 2026, filed 30 Jul 2026.